Iradimed (IRMD) Shares Outstanding (2013 - 2026)

Iradimed (IRMD) has reported Shares Outstanding (Entity) for 14 consecutive years, with $12.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 0.52% year-over-year to $12.8 million in Q2 2026; TTM through Jun 2026 was $12.8 million, a 0.52% increase from a year earlier, with the FY2025 full-year figure at $12.8 million, up 0.57% from the prior year.
• Shares Outstanding (Entity) was $12.8 million for Q2 2026 at Iradimed, roughly flat from $12.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $12.8 million in Q2 2026 and troughed at $12.6 million in Q1 2022.
• A 5-year average of $12.7 million and a median of $12.7 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) rose 2.02% in 2022 and grew 0.27% in 2023, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $12.6 million in 2022, then climbed by 0.55% to $12.7 million in 2023, then advanced by 0.39% to $12.7 million in 2024, then climbed by 0.57% to $12.8 million in 2025, then climbed by 0.04% to $12.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $12.8 million (Q2 2026), $12.8 million (Q1 2026), and $12.8 million (Q4 2025), per Business Quant data.